Three major entities—Sepia Investments, Sage Investment Trust, and Anchor Partners—have offloaded a combined 2.62 million equity shares of Corona Remedies Limited. The sale, conducted via the open market on the NSE on September 10, 2026, reduced their collective shareholding in the company from 13.41% to 9.12%.
Corona Remedies: Major Entities Offload 2.62 Million Shares
Total shares sold: 2,629,880. Combined shareholding reduced from 13.41% to 9.12%.
Reader Takeaway: Large-scale selling by established investors often creates temporary supply pressure on stock price movements.
What just happened
Three institutional entities—Sepia Investments Limited, Sage Investment Trust, and Anchor Partners—have reduced their stake in Corona Remedies Limited. On September 10, 2026, these entities sold a combined total of 2,629,880 equity shares of the pharmaceutical company through an open-market transaction on the National Stock Exchange (NSE).
Why this matters
The sale significantly lowers the combined stake held by these three entities to 9.12% from their previous 13.41%. Sepia Investments Limited was the primary seller, disposing of 2,485,476 shares, bringing its own holding down from 12.68% to 8.62%. Such block exits or significant stake reductions are closely tracked by retail investors as they impact the supply-demand balance and reflect changes in the investment appetite of major shareholders.
Transaction Details
The company confirmed that its total equity share capital remains unchanged at INR 611,600,880, consisting of 61,160,088 shares, each with a face value of INR 10. The sale was executed strictly through open-market channels, ensuring compliance with SEBI (Substantial Acquisition of Shares and Takeovers) regulations.
What to track next
Investors should monitor the price volume action on the NSE following this disclosure and keep an eye on subsequent filings to see if any new institutional buyers have accumulated the shares offloaded by these entities.